Growth Hormone Deficiency Market Business Growth, Trends and Future Scenario by 2027

Market Highlights

Global Growth Hormone Deficiency Market is expected to have a market value of USD 5,243.3 Million by 2027.

Growth Hormone Deficiency (GHD) is a rare type of disorder where the pituitary gland produces an insufficient secretion of growth hormone in the body. GHD can be congenital or developed in a later stage.

Segment Analysis

Global Growth Hormone Deficiency Market is classified into a brand such as Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, and others. In addition, the global growth hormone deficiency market, by application, is segmented into pediatric growth hormone deficiency, Turner syndrome, Idiopathic Short Stature (ISS), small for gestational age, adult growth hormone deficiency, Prader-Willi syndrome, and others. By route of administration, the market is segmented into subcutaneous, intravenous, and intramuscular. The global growth hormone market is segmented by the distribution channel into hospital pharmacies, retail pharmacies, online pharmacies, and specialty pharmacies.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Growth Hormone Deficiency Market— Novo Nordisk A/S, Eli Lily and Company, Novartis AG, and Merck KGaA, and Pfizer.

Key Findings of the Study

• Global Growth Hormone Deficiency Market is estimated to reach USD 5,243.3 Million by 2027 at a CAGR of 4.2% during the assessment period of 2020 to 2027.
• The US accounted for the largest share of the global growth hormone deficiency market due to high uptake rate, the presence of prominent players in the US, and product clearances from regulatory authorities.
• Based on brand, the norditropin segment accounted for the largest market share of 32.33% in 2019.
• On the basis of Application, the pediatric growth hormone deficiency, turner syndrome segment is expected to be the fastest-growing segment during the forecast period at a CAGR of 4.47%.
• Based on Route of Administration, the subcutaneous segment dominated the market with a share of 43.8% in the year 2019.
• Based on Distribution Channel, hospital pharmacies held the largest market share of 40.8% and the e-commerce website segment was the fastest-growing segment with a CAGR of 4.51%

Article source: https://article-realm.com/article/Sports-Recreation/12833-Growth-Hormone-Deficiency-Market-Business-Growth-Trends-and-Future-Scenario-by-2027.html